Gene · 9682
Papers1,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA. | Viruses | 2023 | 38140556 | PubTator, text mining | PubMed |
| Insights into the Role of Histone Methylation in Brain Aging and Potential Therapeutic Interventions. | Int J Mol Sci | 2023 | 38139167 | PubTator, text mining | PubMed |
| In-silico guided chemical exploration of KDM4A fragments hits. | Clin Epigenetics | 2023 | 38129913 | PubTator, text mining | PubMed |
| Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns. | Cancer Cell Int | 2023 | 38129839 | PubTator, text mining | PubMed |
| Retracted: Cantharidin Inhibits Proliferation of Liver Cancer by Inducing DNA Damage via KDM4A-Dependent Histone H3K36 Demethylation. | Evid Based Complement Alternat Med | 2023 | 38125128 | PubTator, text mining | PubMed |
| Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability. | Clin Epigenetics | 2023 | 38093312 | PubTator, text mining | PubMed |
| Inhibition of demethylase by IOX1 modulates chromatin accessibility to enhance NSCLC radiation sensitivity through attenuated PIF1. | Cell Death Dis | 2023 | 38086789 | PubTator, text mining | PubMed |
| Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. | Signal Transduct Target Ther | 2023 | 38072908 | PubTator, text mining | PubMed |
| Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis. | Front Oncol | 2023 | 38045004 | PubTator, text mining | PubMed |
| The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback. | Cell Commun Signal | 2023 | 38037054 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnea in Adults and Ear, Nose, and Throat (ENT) Health: A Narrative Review. | Cureus | 2023 | 38022002 | PubTator, text mining | PubMed |
| Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. | BMC Cancer | 2023 | 38017425 | PubTator, text mining | PubMed |
| Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. | Nutrients | 2023 | 38004113 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development. | Int J Mol Sci | 2023 | 38003512 | PubTator, text mining | PubMed |
| STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition. | Adv Sci (Weinh) | 2023 | 37985839 | PubTator, text mining | PubMed |
| Structure-guided optimisation of N-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α. | Chem Sci | 2023 | 37969593 | PubTator, text mining | PubMed |
| An early prediction model for type 2 diabetes mellitus based on genetic variants and nongenetic risk factors in a Han Chinese cohort. | Front Endocrinol (Lausanne) | 2023 | 37955008 | PubTator, text mining | PubMed |
| Allyl Isothiocyanate Suppresses the Proliferation in Oral Squamous Cell Carcinoma via Mediating the KDM8/CCNA1 Axis. | Biomedicines | 2023 | 37893043 | PubTator, text mining | PubMed |
| Oxygen-regulated post-translation modifications as master signalling pathway in cells. | EMBO Rep | 2023 | 37877678 | PubTator, text mining | PubMed |
| Chromatin: the old and young of it. | Front Mol Biosci | 2023 | 37877123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9682/papers?page=7